Recent Finacing
Recent Raise
Rodin Therapeutics discovers and develops brain-penetrant small-molecule epigenetic modulators targeting specific HDAC complexes, using structural biology, translational synaptic biomarkers, and partnerships with Proteros, Broad, and Biogen.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors